Core Points - Zhejiang Shouxiangu Pharmaceutical Co., Ltd. successfully transferred the registration certificate for "Shouxiangu Brand Dendrobium and American Ginseng Tea" to its wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd. [1] - The transfer of the registration certificate is part of a commitment made by the actual controller of the company and the sole investor of Wuyi County Fungi Research Institute, Li Mingyan, during the company's initial public offering [1] - The successful transfer of the registration certificate will not affect the normal production and sales of the "Shouxiangu Brand Dendrobium and American Ginseng Tea" product [1] Summary by Sections - **Company Actions** - The company has completed the transfer of the registration certificate for a health food product [1] - The transfer is part of fulfilling commitments related to the company's initial public offering [1] - **Regulatory Compliance** - Li Mingyan committed to applying for the cancellation of the Wuyi County Fungi Research Institute after the completion of the transfer of relevant health food registration certificates [1] - The commitment is irrevocable and remains valid from the date of issuance [1] - **Product Impact** - The transfer of the registration certificate will not impact the production and sales of the "Shouxiangu Brand Dendrobium and American Ginseng Tea" [1]

Core Viewpoint - The successful transfer of the registration certificate for "Shouxiangu Brand Dendrobium and American Ginseng Tea" enhances the company's compliance with commitments related to its initial public offering and does not affect the normal production and sales of the product [1] Group 1 - The company’s wholly-owned subsidiary, Jinhua Shouxiangu Pharmaceutical Co., Ltd., has successfully acquired the registration certificate for the health food product [1] - The transfer of the registration certificate has been completed, while the transfer process for related health food product registration approvals is still ongoing [1] - The successful transfer supports the fulfillment of commitments associated with the company's initial public offering [1]